CDC Advisory Panel to Meet on Cases of Rare Syndrome in Vaccinated Americans

Johnson & Johnson COVID-19 vaccines are seen on a table in Los Angeles, Calif., on May 7, 2021. Frederic J. Brown/AFP via Getty Images

A Centers for Disease Control and Prevention (CDC) advisory committee is set to meet Thursday to go over data regarding cases of a rare syndrome in people who have received a COVID-19 vaccine.

The Advisory Committee on Immunization Practices, a panel made up of medical and public health experts who make recommendations on vaccinations, will hear from officials on the occurrence of Guillain-Barré syndrome in Americans who have received Johnson & Johnson’s COVID-19 jab, according to a draft agenda.